Literature DB >> 25178686

Conjunctival expression of the P2Y2 receptor and the effects of 3% diquafosol ophthalmic solution in dogs.

Kunihiko Terakado1, Takuya Yogo2, Yukihiro Kohara3, Satoshi Soeta3, Yoshinori Nezu2, Yasuji Harada2, Yasushi Hara2, Hajime Amasaki3, Masahiro Tagawa2.   

Abstract

Conjunctival epithelial and goblet cell P2Y2 nucleotide receptors regulate ion transport and secretory function. Diquafosol is a P2Y2 purinergic receptor agonist that stimulates secretion of aqueous tear components from conjunctival epithelial cells and secretion of mucin from conjunctival goblet cells. In humans suffering from keratoconjunctivitis sicca (dry eye), topical administration of diquafosol improves corneal epithelial integrity and stabilises the tear film. The aim of the present study was to investigate P2Y2 receptor expression and to determine the effect of topical administration of diquafosol on mucin and aqueous tear production in dogs. Canine conjunctival P2Y2 receptor expression was evaluated by Western blotting and immunohistochemical analysis. The effect of diquafosol on mucin secretion was evaluated by examining mucin-5 subtype AC (MUC5AC) concentration in tears. The effect of diquafosol on aqueous secretions was evaluated by performing the Schirmer tear test (STT) and phenol red thread test. Expression of the P2Y2 receptor was confirmed in canine bulbar and palpebral conjunctivae and receptors were identified at the conjunctival epithelial and goblet cell surface. Tear MUC5AC concentration significantly increased after administration of 3% diquafosol ophthalmic solution, although neither STT nor phenol red thread test values showed any significant change after diquafosol instillation. Topical ocular administration of 3% diquafosol might improve corneal epithelial disorders in dogs through stabilisation of the tear film, by virtue of an increase in MUC5AC secretion.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Conjunctiva; Diquafosol; Dog; Mucin secretion; P2Y(2) receptor

Mesh:

Substances:

Year:  2014        PMID: 25178686     DOI: 10.1016/j.tvjl.2014.05.022

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  7 in total

Review 1.  Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatment.

Authors:  Mark S Milner; Kenneth A Beckman; Jodi I Luchs; Quentin B Allen; Richard M Awdeh; John Berdahl; Thomas S Boland; Carlos Buznego; Joseph P Gira; Damien F Goldberg; David Goldman; Raj K Goyal; Mitchell A Jackson; James Katz; Terry Kim; Parag A Majmudar; Ranjan P Malhotra; Marguerite B McDonald; Rajesh K Rajpal; Tal Raviv; Sheri Rowen; Neda Shamie; Jonathan D Solomon; Karl Stonecipher; Shachar Tauber; William Trattler; Keith A Walter; George O Waring; Robert J Weinstock; William F Wiley; Elizabeth Yeu
Journal:  Curr Opin Ophthalmol       Date:  2017-01       Impact factor: 3.761

Review 2.  Targeting purinergic receptors to attenuate inflammation of dry eye.

Authors:  Jia-Ning Wang; Hua Fan; Jian-Tao Song
Journal:  Purinergic Signal       Date:  2022-02-26       Impact factor: 3.765

3.  Do Cyclosporine A, an IL-1 Receptor Antagonist, Uridine Triphosphate, Rebamipide, and/or Bimatoprost Regulate Human Meibomian Gland Epithelial Cells?

Authors:  Wendy R Kam; Yang Liu; Juan Ding; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-08-01       Impact factor: 4.799

4.  Osteoporosis and dry eye syndrome: A previously unappreciated association that may alert active prevention of fall.

Authors:  Yu-Ting Jeng; Shu-Yi Lin; Hsiao-Yun Hu; Oscar K Lee; Li-Lin Kuo
Journal:  PLoS One       Date:  2018-11-05       Impact factor: 3.240

5.  Assessment of mucin-related gene alterations following treatment with rebamipide ophthalmic suspension in Sjögren's syndrome-associated dry eyes.

Authors:  Jun Shoji; Noriko Inada; Akiko Tomioka; Satoru Yamagami
Journal:  PLoS One       Date:  2020-11-24       Impact factor: 3.240

6.  Transmembrane Mucin 1 Blocks Fluorescein Ingress to Corneal Epithelium.

Authors:  Yi-Chen Sun; Kai-Feng Hung; Tzu-Yun Li; Yu-An Chang; Po-Ting Yeh; Fung-Rong Hu
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-02-01       Impact factor: 4.799

7.  Expression patterns of conjunctival mucin 5AC and aquaporin 5 in response to acute dry eye stress.

Authors:  Dhruva Bhattacharya; Li Yu; Mingwu Wang
Journal:  PLoS One       Date:  2017-11-07       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.